Heterozygous CLCN1 mutations can modulate phenotype in sodium channel myotonia.

Neuromuscul Disord

Assistance Publique-Hôpitaux de Paris, National Reference Center for Neuromuscular Channelopathies, Hôpital Pitié-Salpêtrière, Paris 75013, France; CNRS-INSERM-UPMC UMR 1127-7225, Institut Cerveau Moelle, Hôpital Pitié-Salpêtrière, Paris 75013, France.

Published: November 2014

Nondystrophic myotonias are characterized by muscle stiffness triggered by voluntary movement. They are caused by mutations in either the CLCN1 gene in myotonia congenita or in the SCN4A gene in paramyotonia congenita and sodium channel myotonias. Clinical and electrophysiological phenotypes of these disorders have been well described. No concomitant mutations in both genes have been reported yet. We report five patients from three families showing myotonia with both chloride and sodium channel mutations. Their clinical and electrophysiological phenotypes did not fit with the phenotype known to be associated with the mutation initially found in SCN4A gene, which led us to screen and find an additional mutation in CLCN1 gene. Our electrophysiological and clinical observations suggest that heterozygous CLCN1 mutations can modify the clinical and electrophysiological expression of SCN4A mutation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nmd.2014.06.439DOI Listing

Publication Analysis

Top Keywords

sodium channel
12
clinical electrophysiological
12
heterozygous clcn1
8
clcn1 mutations
8
clcn1 gene
8
scn4a gene
8
electrophysiological phenotypes
8
mutations
5
mutations modulate
4
modulate phenotype
4

Similar Publications

This study explored the vasodilatory mechanisms of the sodium-glucose cotransporter-2 inhibitor remogliflozin using femoral arteries of rabbits. Remogliflozin dilated femoral arterial rings pre-contracted with phenylephrine in a concentration-dependent manner. Pretreatment with the Ca-sensitive K channel inhibitor (paxilline), the ATP-sensitive K channel inhibitor (glibenclamide), or the inwardly rectifying K channel inhibitor (Ba) did not alter the vasodilatory effect.

View Article and Find Full Text PDF

Analysis of initial seizure characteristics in patients with infantile onset genetic epilepsy.

Brain Dev

January 2025

Department of Pediatrics, Pediatric Clinical Neuroscience Center, Seoul National University Children's Hospital, Seoul National University College of Medicine, 101 Daehakro, Jongno-Gu, Seoul 03080, Republic of Korea. Electronic address:

Objective: The present study aimed to investigate the initial clinical features of infantile-onset genetic epilepsy and compare initial seizure variables and responses to sodium channel blockers between SCN1A and non-SCN1A group.

Methods: We selected 122 patients, comprising 58 patients with SCN1A mutations and 64 patients with mutations in other than SCN1A, from our institutional database.

Results: Patients identified in the SCN1A group tended to present with fever, prolonged seizure duration, and hemiclonic seizure semiology.

View Article and Find Full Text PDF

Background: Reduction of intracellular Na accumulation through late Na current inhibition has been recognized as a target for cardiac Ca handling which underlies myocardial contractility and relaxation in heart failure (HF). Riluzole, an Na channel blocker with enhancement of Ca-activated K channel function, used for management of amyotrophic lateral sclerosis (ALS), is effective in suppressing Ca leak and therefore may improve cardiac function.

Objectives: The study aim was to investigate whether riluzole lowers HF incidence.

View Article and Find Full Text PDF

Background: Alzheimer's disease is associated with neurotoxic amyloid-beta (Aβ) plaques. Studies in mice demonstrated that cerebrospinal fluid (CSF) clearance, if impaired, reduces Aβ clearance by 70% and that sleep enhances CSF clearance via expanding extracellular space by 60%. However, the impact of sleep on extracellular volume in human remains unclear due to lack of non-invasive technology.

View Article and Find Full Text PDF

The role played by anionic channels in diabetic kidney disease (DKD) is not known. Chloride channel accessory 1 (CLCA1) facilitates the activity of TMEM16A (Anoctamin-1), a Ca2+-dependent Cl- channel. We examined if CLCA1/TMEM16A had a role in DKD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!